![](/img/cover-not-exists.png)
Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study
Nabors, L. B., Fink, K. L., Mikkelsen, T., Grujicic, D., Tarnawski, R., Nam, D. H., Mazurkiewicz, M., Salacz, M., Ashby, L., Zagonel, V., Depenni, R., Perry, J. R., Hicking, C., Picard, M., Hegi, M. EVolume:
17
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/nou356
Date:
May, 2015
File:
PDF, 482 KB
english, 2015